GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a remarkable innovation in how we treat type 2 diabetes . These new therapies help mimicking the body’s natural GLP-1 process, which https://bacteriastatic-water837177.theblogfairy.com/profile